By fluorescence microscopy, we observed an increased number of fluorescent cells (also brighter) in CPZ-treated anchorage-dependent GBM cells when compared with control cells (CTL) (Fig. 5, left), thus indicating enhanced levels of superoxide radicals. This evidence concerns the gene CPZ and glioblastoma.